Efficacy, Adherence and Side Effects of PrEP for HIV-1 Prevention

Wanyi Fang, Bongani I. Mphoyi, Dineo R. Motake, Jianxin Liu, Wenshuang Li, F. Mei, S. Lai, Jun Wang
{"title":"Efficacy, Adherence and Side Effects of PrEP for HIV-1 Prevention","authors":"Wanyi Fang, Bongani I. Mphoyi, Dineo R. Motake, Jianxin Liu, Wenshuang Li, F. Mei, S. Lai, Jun Wang","doi":"10.5539/ijb.v11n4p80","DOIUrl":null,"url":null,"abstract":"Each year, approximately two million new HIV infections are reported worldwide. About one decade ago, a company called Gilead Sciences Inc. discovered a new HIV prevention method named as pre-exposure prophylaxis (PrEP). When high adherence was kept among high-risk population, PrEP efficacy could reach as high as 99%. However, the adverse effects have been reported from time to time, including low efficacy in certain cases, adherence difficulties and medicinal side effects. In this review, we would summarize the progress of PrEP since its introduction in order to provide insights for HIV prevention.","PeriodicalId":13849,"journal":{"name":"International Journal of Biology","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2019-08-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"4","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Biology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5539/ijb.v11n4p80","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 4

Abstract

Each year, approximately two million new HIV infections are reported worldwide. About one decade ago, a company called Gilead Sciences Inc. discovered a new HIV prevention method named as pre-exposure prophylaxis (PrEP). When high adherence was kept among high-risk population, PrEP efficacy could reach as high as 99%. However, the adverse effects have been reported from time to time, including low efficacy in certain cases, adherence difficulties and medicinal side effects. In this review, we would summarize the progress of PrEP since its introduction in order to provide insights for HIV prevention.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
PrEP预防HIV-1的疗效、依从性和副作用
每年,全世界大约有200万新的艾滋病毒感染报告。大约十年前,一家名为吉利德科学公司的公司发现了一种新的艾滋病预防方法,称为暴露前预防(PrEP)。当高危人群保持高依从性时,PrEP的疗效可高达99%。然而,不良反应时有报道,包括在某些情况下低疗效,坚持困难和药物副作用。本文就PrEP自问世以来的进展进行综述,以期为预防艾滋病提供参考。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Antibiotic Resistance Mechanisms and Strategies for Combating Resistance in Germany Role of Non-Coding RNAs in Gene Regulation in Brazil Influence of Environmental Factors on Embryonic Development and Fetal Programming in South Africa Stress Factors Affecting the Cryopreservation of Biological Components of Seed Virus for Avian Influenza Vaccine Production Capability of Workers of the Ant Myrmica sabuleti to Categorize Numbers of Elements into Even and Odd
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1